XML 21 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net (loss) income $ (34,381) $ 74,809
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss (gain) on sale or write down of assets, net 37,512 (49,565)
Depreciation and amortization 81,524 84,551
Amortization of premium on mortgage notes payable (235) (926)
Amortization of share and unit-based plans 11,003 13,805
Straight-line rent adjustment (2,683) (1,884)
Amortization of above and below-market leases 152 193
Provision for doubtful accounts 1,354 1,318
Income tax benefit (2,949) (3,484)
Equity in income of unconsolidated joint ventures (16,872) (15,843)
Distributions of income from unconsolidated joint ventures 155 0
Change in fair value of financing arrangement obligation 4,382 0
Co-venture expense 0 3,877
Changes in assets and liabilities, net of acquisitions and dispositions:    
Tenant and other receivables 11,699 8,757
Other assets 11,473 12,618
Due from affiliates (2,512) (12,015)
Accounts payable and accrued expenses 13,239 4,285
Other accrued liabilities (17,893) (17,792)
Net cash provided by operating activities 94,968 102,704
Cash flows from investing activities:    
Development, redevelopment, expansion and renovation of properties (49,242) (33,013)
Property improvements (4,968) (4,350)
Proceeds from repayment of notes receivable 202 212
Deferred leasing costs (13,384) (11,267)
Distributions from unconsolidated joint ventures 418,333 114,528
Contributions to unconsolidated joint ventures (40,990) (26,593)
Proceeds from sale of assets 1,450 167,649
Net cash provided by investing activities 311,401 207,166
Cash flows from financing activities:    
Proceeds from mortgages, bank and other notes payable 120,000 200,000
Payments on mortgages, bank and other notes payable (387,643) (263,927)
Deferred financing costs (132) (142)
Stock repurchases 0 (132,550)
Redemption of noncontrolling interests (65) (15)
Dividends and distributions (113,782) (110,621)
Distributions to co-venture partner 0 (4,302)
Net cash used in financing activities (381,622) (311,557)
Net increase (decrease) in cash and cash equivalents 24,747 (1,687)
Cash, cash equivalents and restricted cash, beginning of period 143,105 143,997
Cash, cash equivalents and restricted cash, end of period 167,852 142,310
Supplemental cash flow information:    
Cash payments for interest, net of amounts capitalized 46,418 40,462
Non-cash investing and financing transactions:    
Accrued development costs included in accounts payable and accrued expenses and other accrued liabilities 36,286 24,712
Accrued stock repurchase costs 0 8,552
Conversion of Operating Partnership Units to common stock $ 0 $ 638